BIOLASE, Inc. BIOL
Set alert
At close · Oct 2
- Open
- 0.049
- Prev close
- 0.02
- Mkt cap
- 2.59M
- Vol
- 2.67M
- Avg vol
- 2.03M
- EPS
- -11.97
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0157
- High
- 0.052
- Forward P/E
- -0.86
- Beta
- 0.72
- Short ratio
- 1.09
- Inst. own
- 8.97%
- Dividend
- 0.00
- Ex-div date
- Jun 23, 2005
- Earnings
- Nov 14, 2024
- 50-d avg
- 0.1336
- 200-d avg
- 0.66915
- 1y target
- 1.95
Key statistics
- Market cap
- 2.59M
- Enterprise value
- 14.29M
- Trailing P/E
- 0.00
- Forward P/E
- -0.86
- PEG ratio
- -0.01
- Price / sales
- 0.05
- Price / book
- 0.00
- EPS (TTM)
- -11.97
- Beta
- 0.72
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -43.56%
- Revenue (TTM)
- 48.83M
- Revenue growth
- -3.20%
- Free cash flow
- 491.75K
- Total cash
- 6.39M
- Total debt
- 15.45M
- Return on equity
- -504.76%
- Shares outstanding
- 33.40M
- Short % of float
- 5.00%
- 50-day average
- 0.1336
- 200-day average
- 0.66915
Analyst view
Consensus: buy
- Target (low)
- 0.40
- Target (mean)
- 1.95
- Target (high)
- 3.50
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 14, 2024
Expected Nov 14, 2024. Consensus EPS estimate -0.07.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.03 | — | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Mar 21, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
About BIOLASE, Inc.
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- biolase.com
News
- MegaGen and BIOLASE Invest Nearly $1 Million to Expand Manufacturing Infrastructure at Corona, California Facility
- BIOLASE Showcases Advanced YSGG Laser Solutions for Periodontal and Implant Care at GNYDM 2025
- BIOLASE Showcases Breakthrough YSGG Laser Protocol for Predictable Periodontitis Treatment at AAP 2025
- BIOLASE Emerges Stronger Than Ever Under New Ownership by MegaGen Implant
- BIOLASE Voluntarily Initiates Chapter 11 Proceedings
- BIOLASE Reports 2024 Second Quarter Results; Achieves 40% Gross Margin as Global Consumable Sales Strengthen
- BIOLASE Announces Delisting from Nasdaq
- Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- BIOLASE, Inc. (BIOL) Q1 2024 Earnings Call Transcript
- Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability
Your note
Sign in to keep a note on BIOL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEAVER JOHN R | Chief Executive Officer | Purchase | Nov 29, 2021 | 621,530 |
| CLARK PAUL N | Director | Conversion of Exercise of derivative security | Jun 29, 2017 | 0 |
| FEINBERG LARRY N | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 8, 2020 | 0 |
| FLYNN HAROLD C JR | Chief Executive Officer | Conversion of Exercise of derivative security | Dec 4, 2017 | 0 |
| LORD JONATHAN T. | Director | Sale | Dec 6, 2022 | 59,925 |
| NORBE TODD A | Chief Executive Officer | Purchase | Dec 12, 2018 | 15,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Walleye Capital LLC | 1.36% | 14,205 | 100.43K | Jun 29, 2023 |
| Zhang Financial LLC | 1.16% | 12,078 | 22.46K | Sep 29, 2023 |
| Acadian Asset Management. LLC | 0.92% | 9,617 | 67.99K | Jun 29, 2023 |
| Avantax Planning Partners, Inc. | 0.52% | 5,441 | 38.47K | Jun 29, 2023 |
| Millennium Management Llc | 0.39% | 4,068 | 28.76K | Jun 29, 2023 |
| Perkins Capital Management, Inc. | 0.15% | 1,572 | 11.11K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.09% | 926 | 6.55K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.03% | 292 | 2.38K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.01% | 68 | 554 | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.01% | 107 | 872 | May 30, 2023 |